Proteome Sciences Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0003104196
GBP
0.03
0.01 (69.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Proteome Sciences Plc stock-summary
stock-summary
Proteome Sciences Plc
Pharmaceuticals & Biotechnology
Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.
Company Coordinates stock-summary
Company Details
Hamilton House, Mabledon Place , LONDON None : WC1H 9BB
stock-summary
Tel: 44 20 70432116
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Christopher Pearce
Executive Chairman of the Board
Dr. Mariola Sohngen
Chief Executive Officer, Director
Mr. Geoffrey Ellis
Finance Director, Company Secretary, Director
Dr. Ian Pike
Chief Scientific Officer, Executive Director
Dr. Gee See Chee
Director of Personalised Medicine
Mr. Martin Diggle
Non-Executive Director
Mr. Roger McDowell
Non-Executive Director
Dr. Ursula Ney
Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 7 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.66

stock-summary
Return on Equity

38.83%

stock-summary
Price to Book

-0.77